Epigenetic mechanisms of gene expression regulation in neurological diseases

• Autorzy: Gos M.
• Języki publikacji: EN

Abstrakty

EN

Neurological diseases are a heterogenous group of disorders that are related to alterations in nervous system function. The genetic background of neurological diseases is heterogenous and may include chromosomal aberrations, specific gene mutations and epigenetic defects. This review is aimed at presenting of selected diseases that are associated with different epigenetic alterations. The imprinting defects on chromosome 15 are the cause of Prader-Willi and Angelman syndromes that both are characterized by intellectual disability, developmental delay and specific behavioral phenotype. Besides the imprinting defect, these diseases can also be caused by deletion of chromosome 15 or uniparental disomy. Aberrant epigenetic regulation is also specific for Fragile X syndrome that is caused by expansion of CGG repeats in the FMR1 gene that leads to global methylation of the promoter region and repression of FMR1 transcription. A number of neurological diseases, mainly associated with intellectual impairment, may be caused by mutations in genes encoding proteins involved in epigenetic regulation. The number of such diseases is rapidly growing thanks to the implementation of genomic sequencing for the identification of their molecular causes. One of the best known diseases linked to defects in epigenetic modifiers is Rett syndrome caused by a mutation in the MECP2 gene or its variant - Rett-like syndrome caused by a mutation in CDKL5 or FOXG1 genes. As the epigenetic signature is potentially reversible, much attention is focused on possible therapies with drugs that influence DNA or histone modifications. This is especially important in the case of neurological disorders in which epigenetic changes are observed as the effect of the disease.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2013
• Tom: 73
• Numer: 1
• Opis fizyczny: p.19-37,fig.,ref.

Twórcy

autor

Gos M.

• Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland

Bibliografia

• Ausio J, Levin DB, De Amorim GV, Bakker S, Macleod PM (2003) Syndromes of disordered chromatin remodeling. Clin Genet 64: 83-95.
• Bahi-Buisson N, Bienvenu T (2012) CDKL5-Related Disorders: From Clinical Description to Molecular Genetics. Mol Syndromol 2: 137-152.
• Banerjee A, Castro J, Sur M (2012) Rett syndrome: genes, synapses, circuits, and therapeutics. Front Psychiatry 3: 34.
• Ben-Ami I, Edel Y, Barel O, Vaknin Z, Herman A, Maymon R (2011) Do assisted conception twins have an increased risk for anencephaly? Hum Reprod 26: 3466-3471.
• Bian S, Sun T (2011) Functions of noncoding RNAs in neu¬ral development and neurological diseases. Mol Neurobiol 44: 359-373.
• Bicker S, Schratt G (2008) microRNAs: tiny regulators of synapse function in development and disease. J Cell Mol Med 12: 1466-1476.
• Bijlsma EK, Collins A, Papa FT, Tejada MI, Wheeler P, Peeters EA, Gijsbers AC, van de Kamp JM, Kriek M, Losekoot M, Broekma AJ, Crolla JA, Pollazzon M, Mucciolo M, Katzaki E, Disciglio V, Ferreri MI, Marozza A, Mencarelli MA, Castagnini C, Dosa L, Ariani F, Mari F, Canitano R, Hayek G, Botella MP, Gener B, Minguez M, Renieri A, Ruivenkamp CA (2012) Xq28 duplications including MECP2 in five females: Expanding the pheno- type to severe mental retardation. Eur J Med Genet 55: 404-413.
• Buiting K (2010) Prader-Willi and Angelman syndrome. Am J Med Genet C Semin Med Genet 154C: 365-376.
• Butler MG (2009) Genomic imprinting disorders in humans: A mini-review. J Assist Reprod Genet 26: 477-486.
• Calabrese R, Zampieri M, Mechelli R, Annibali V, Guastafierro T, Ciccarone F, Coarelli G, Umeton R, Salvetti M, Caiafa P (2012) Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood. Mult Scler 18: 299-304.
• Campeau PM, Lu JT, Dawson BC, Fokkema IF, Robertson SP, Gibbs RA, Lee BH (2012) The KAT6B-related disor¬ders genitopatellar syndrome and Ohdo/SBBYS syn¬drome have distinct clinical features reflecting distinct molecular mechanisms. Hum Mutat 33: 1520-1525.
• Chamberlain SJ, Lalande M (2010a) Angelman syndrome, a genomic imprinting disorder of the brain. J Neurosci 30: 9958-9963.
• Chamberlain SJ, Lalande M (2010b) Neurodevelopmental disorders involving genomic imprinting at human chro¬mosome 15q11-q13. Neurobiol Dis 39: 13-20.
• Chen Q, Zhu YC, Yu J, Miao S, Zheng J, Xu L, Zhou Y, Li D, Zhang C, Tao J, Xiong ZQ (2010) CDKL5, a protein asso¬ciated with rett syndrome, regulates neuronal morphogen¬esis via Racl signaling. J Neurosci 30: 12777-12786.
• Chen M, Norman RJ, Heilbronn LK (2011) Does in vitro fertilisation increase type 2 diabetes and cardiovascular risk? Curr Diabetes Rev 7: 426-432.
• Chiurazzi P, Schwartz CE, Gecz J, Neri G (2008) XLMR genes: update 2007. Eur J Hum Genet 16: 422-434.
• Choi YJ, Kim SI, Lee JW, Kwon YS, Lee HJ, Kim SS, Chun W (2012) Suppression of aggregate formation of mutant huntingtin potentiates CREB-binding protein sequestra¬tion and apoptotic cell death. Mol Cell Neurosci 49: 127-137.
• Choufani S, Shuman C, Weksberg R (2010) Beckwith- Wiedemann syndrome. Am J Med Genet C Semin Med Genet 154C: 343-354.
• Christodoulou J, Ho G (2012) MECP2-related disorders. In: GeneReviews™ [Internet] (Pagon RA, Bird TD, Dolan CR, et al., Eds). University of Washington, Seattle, WA. [Available at: http://www.ncbi.nlm.nih.gov/books/ NBK1497/]
• Cowansage KK, LeDoux JE, Monfils MH (2010) Brain- derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Curr Mol Pharmacol 3: 12-29.
• Cukier HN, Lee JM, Ma D, Young JI, Mayo V, Butler BL, Ramsook SS, Rantus JA, Abrams AJ, Whitehead PL, Wright HH, Abramson RK, Haines JL, Cuccaro ML, Pericak-Vance MA, Gilbert JR (2012) The expanding role of MBD genes in autism: Identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1. Autism Res 5: 385-397.
• Cukier HN, Rabionet R, Konidari I, Rayner-Evans MY, Baltos ML, Wright HH, Abramson RK, Martin ER, Cuccaro ML, Pericak-Vance MA, Gilbert JR (2010) Novel variants identified in methyl-CpG-binding domain genes in autistic individuals. Neurogenetics 11: 291-303.
• Dagli AI, Williams CA (2011) Angelman syndrome. In: GeneReviews™ [Internet] (Pagon RA, Bird TD, Dolan CR, et al., Eds). University of Washington, Seattle, WA [Available at http://www.ncbi.nlm.nih.gov/books/ NBK1144/]
• de Leeuw N, Bulk S, Green A, Jaeckle-Santos L, Baker LA, Zinn AR, Kleefstra T, van der Smagt JJ, Vianne Morgante AM, de Vries BB, van Bokhoven H, de Brouwer AP (2010) UBE2A deficiency syndrome: Mild to severe intellectual disability accompanied by seizures, absent speech, urogenital, and skin anomalies in male patients. Am J Med Genet A 152A: 3084-3090.
• Deardorff MA, Bando M, Nakato R, Watrin E, Itoh T, Minamino M, Saitoh K, Komata M, Katou Y, Clark D, Cole KE, De Baere E, Decroos C, Di Donato N, Ernst S, Francey LJ, Gyftodimou Y, Hirashima K, Hullings M, Ishikawa Y, Jaulin C, Kaur M, Kiyono T, Lombardi PM, Magnaghi-Jaulin L, Mortier GR, Nozaki N, Petersen MB, Seimiya H, Siu VM, Suzuki Y, Takagaki K, Wilde JJ, Willems PJ, Prigent C, Gillessen-Kaesbach G, Christianson DW, Kaiser FJ, Jackson LG, Hirota T, Krantz ID, Shirahige K (2012) HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle. Nature 489: 313-317.
• Díaz de León-Guerrero S, Pedraza-Alva G, Pérez-Martínez L (2011) In sickness and in health: the role of methyl- CpG binding protein 2 in the central nervous system. Eur J Neurosci 33: 1563-1574.
• Dindot SV, Antalffy BA, Bhattacharjee MB, Beaudet AL (2008) The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet 17: 111-118.
• Driscoll DJ, Miller JL, Schwartz S (2012) Prader-Willi syn¬drome. In: GeneReviews™ [Internet] (Pagon RA, Bird TD, Dolan CR, et al., Eds). University of Washington, Seattle, WA. [Available at: http://www.ncbi.nlm.nih.gov/ books/NBK1330/]
• Eggermann T (2010) Russell-Silver syndrome. Am J Med Genet C Semin Med Genet 154C: 355-364.
• Ehrlich M, Sanchez C, Shao C, Nishiyama R, Kehrl J, Kuick R, Kubota T, Hanash SM (2008) ICF, an immunodefi¬ciency syndrome: DNA methyltransferase 3B involve¬ment, chromosome anomalies, and gene dysregulation. Autoimmunity 41: 253-271.
• Fehr S, Wilson M, Downs J, Williams S, Murgia A, Sartori S, Vecchi M, Ho G, Polli R, Psoni S, Bao X, de Klerk N, Leonard H, Christodoulou J (2013) The CDKL5 disorder is an independent clinical entity associated with early- onset encephalopathy. Eur J Hum Genet 21: 266-273.
• Feinberg AP (2008) Epigenetics at the epicenter of modern medicine. JAMA 299: 1345-1350.
• Florian C, Bahi-Buisson N, Bienvenu T (2012) FOXG1- Related Disorders: From Clinical Description to Molecular Genetics. Mol Syndromol 2: 153-163.
• Froyen G, Corbett M, Vandewalle J, Jarvela I, Lawrence O, Meldrum C, Bauters M, Govaerts K, Vandeleur L, Van Esch H, Chelly J, Sanlaville D, van Bokhoven H, Ropers HH, Laumonnier F, Ranieri E, Schwartz CE, Abidi F, Tarpey PS, Futreal PA, Whibley A, Raymond FL, Stratton MR, Fryns JP, Scott R, Peippo M, Sipponen M, Partington
• M, Mowat D, Field M, Hackett A, Marynen P, Turner G, Gecz J (2008) Submicroscopic duplications of the hydrox- ysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. Am J Hum Genet 82: 432-443.
• Garber KB, Visootsak J, Warren ST (2008) Fragile X syn¬drome. Eur J Hum Genet 16: 666-672.
• Gecz J, Shoubridge C, Corbett M (2009) The genetic land¬scape of intellectual disability arising from chromosome X. Trends Genet 25: 308-316.
• Gendrel AV, Heard E (2011) Fifty years of X-inactivation research. Development 138: 5049-5055.
• Gibson WT, Hood RL, Zhan SH, Bulman DE, Fejes AP, Moore R, Mungall AJ, Eydoux P, Babul-Hiiji R, An J, Marra MA; FORGE Canada Consortium, Chitayat D, Boycott KM, Weaver DD, Jones SJ (2012) Mutations in EZH2 cause Weaver syndrome. Am J Hum Genet 90: 110-118.
• Godler DE, Tassone F, Loesch DZ, Taylor AK, Gehling F, Hagerman RJ, Burgess T, Ganesamoorthy D, Hennerich D, Gordon L, Evans A, Choo KH, Slater HR (2010) Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. Hum Mol Genet 19: 1618-1632.
• Gos M, Szpecht-Potocka A (2002) Genetic basis of neural tube defects. II. Genes correlated with folate and methi¬onine metabolism. J Appl Genet 43: 511-524.
• Guerrini R, Parrini E (2012) Epilepsy in Rett syndrome, and CDKL5- and FOXG1 -gene-related encephalopathies. Epilepsia 53: 2067-2078.
• El Hajj N, Haaf T (2013) Epigenetic disturbances in in vitro cultured gametes and embryos: implications for human assisted reproduction. Fertil Steril. 2013 Jan 25. pii: S0015-0282(13)00006-X. [Epub ahead of print]
• Harakalova M, van den Boogaard MJ, Sinke R, van Lieshout S, van Tuil MC, Duran K, Renkens I, Terhal PA, de Kovel C, Nijman IJ, van Haelst M, Knoers NVAM, van Haaften G, Kloosterman W, Hennekam RCM, Cuppen E, Ploos van Amstel HK (2012) X-exome sequencing identifies a HDAC8 variant in a large pedigree with X-linked intel¬lectual disability, truncal obesity, gynaecomastia, hypog- onadism and unusual face. J Med Genet 49: 539-543.
• Horsthemke B, Buiting K (2006) Imprinting defects on human chromosome 15. Cytogenet Genome Res 113: 292-299.
• Horsthemke B, Wagstaff J (2008) Mechanisms of imprinting of the Prader-Willi/Angelman region. Am J Med Genet A 146A: 2041-2052.
• Horsthemke B (2010) Mechanisms of imprint dysregulation. Am J Med Genet C Semin Med Genet 154C: 321-328.
• Huang HS, Allen JA, Mabb AM, King IF, Miriyala J, Taylor¬Blake B, Sciaky N, Dutton JW Jr, Lee HM, Chen X, Jin J, Bridges AS, Zylka MJ, Roth BL, Philpot BD (2011) Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature 481: 185-9.
• Ikegami K, Ohgane J, Tanaka S, Yagi S, Shiota K (2009) Interplay between DNA methylation, histone modifica¬tion and chromatin remodeling in stem cells and during development. Int J Dev Biol 53: 203-214.
• Iliadou AN, Janson PC, Cnattingius S (2011) Epigenetics and assisted reproductive technology. J Intern Med 270: 414-420.
• Isles AR, Wilkinson LS (2000) Imprinted genes, cognition and behaviour. Trends Cogn Sci 4: 309-318.
• Jin DK (2012) Endocrine problems in children with Prader- Willi syndrome: special review on associated genetic aspects and early growth hormone treatment. Korean J Pediatr 55: 224-231.
• Jones WD, Dafou D, McEntagart M, Woollard WJ, Elmslie FV, Holder-Espinasse M, Irving M, Saggar AK, Smithson S, Trembath RC, Deshpande C, Simpson MA (2012) De novo mutations in MLL cause Wiedemann-Steiner syn¬drome. Am J Hum Genet 91: 358-364.
• Kameshita I, Sekiguchi M, Hamasaki D, Sugiyama Y, Hatano N, Suetake I, Tajima S, Sueyoshi N (2008) Cyclin-dependent kinase-like 5 binds and phosphorylates DNA methyltransferase 1. Biochem Biophys Res Commun 377: 1162-1167.
• Kantor B, Shemer R, Razin A (2006) The Prader-Willi/ Angelman imprinted domain and its control center. Cytogenet Genome Res 113: 300-305.
• Kelly TK, De Carvalho DD, Jones PA (2010) Epigenetic modifications as therapeutic targets. Nat Biotechnol 28: 1069-1078.
• Kim HG, Kim HT, Leach NT, Lan F, Ullmann R, Silahtaroglu A, Kurth I, Nowka A, Seong IS, Shen Y, Talkowski ME, Ruderfer D, Lee JH, Glotzbach C, Ha K, Kjaergaard S, Levin AV, Romeike BF, Kleefstra T, Bartsch O, Elsea SH, Jabs EW, MacDonald ME, Harris DJ, Quade BJ, Ropers HH, Shaffer LG, Kutsche K, Layman LC, Tommerup N, Kalscheuer VM, Shi Y, Morton CC, Kim CH, Gusella JF (2012) Translocations disrupting PHF21A in the Potocki- Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies. Am J Hum Genet 91: 56-72.
• Kinoshita T, Ikeda Y, Ishikawa R (2008) Genomic imprinting: a balance between antagonistic roles of parental chromosomes. Semin Cell Dev Biol 19: 574-579.
• Kishi N, Macklis JD (2005) Dissecting MECP2 function in the central nervous system. J Child Neurol 20: 753-759.
• Kleefstra T, Kramer JM, Neveling K, Willemsen MH, Koemans TS, Vissers LE, Wissink-Lindhout W, Fenckova M, van den Akker WM, Kasri NN, Nillesen WM, Prescott T, Clark RD, Devriendt K, van Reeuwijk J, de Brouwer AP, Gilissen C, Zhou H, Brunner HG, Veltman JA, Schenck A, van Bokhoven H (2012) Disruption of an EHMTl-associated chromatin-modification module causes intellectual disability. Am J Hum Genet 91: 73-82.
• Klein CJ, Botuyan MV, Wu Y, Ward CJ, Nicholson GA, Hammans S, Hojo K, Yamanishi H, Karpf AR, Wallace DC, Simon M, Lander C, Boardman LA, Cunningham JM, Smith GE, Litchy WJ, Boes B, Atkinson EJ, Middha S, B Dyck PJ, Parisi JE, Mer G, Smith DI, Dyck PJ (2011) Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet 43: 595-600.
• Knudsen GP, Neilson TC, Pedersen J, Kerr A, Schwartz M, Hulten M, Bailey ME, Orstavik KH (2006) Increased skewing of X chromosome inactivation in Rett syndrome patients and their mothers. Eur J Hum Genet 14: 1189¬1194.
• Kobow K, Blümcke I (2011) The methylation hypothesis: do epigenetic chromatin modifications play a role in epilep- togenesis? Epilepsia 52 (Suppl 4): 15-19.
• Kramer JM, van Bokhoven H (2009) Genetic and epigenetic defects in mental retardation Int J Biochem Cell Biol 41: 96-107.
• Legendre M, Gonzales M, Goudefroye G, Bilan F, Parisot P, Perez MJ, Bonnière M, Bessières B, Martinovic J, Delezoide AL, Jossic F, Fallet-Bianco C, Bucourt M, Tantau J, Loget P, Loeuillet L, Laurent N, Leroy B, Salhi H, Bigi N, Rouleau C, Guimiot F, Quélin C, Bazin A, Alby C, Ichkou A, Gesny R, Kitzis A, Ville Y, Lyonnet S, Razavi F, Gilbert-Dussardier B, Vekemans M, Attié- Bitach T (2012) Antenatal spectrum of CHARGE syn¬drome in 40 fetuses with CHD7 mutations. J Med Genet 49: 698-707.
• Lennartsson A, Ekwall K (2009) Histone modification pat¬terns and epigenetic codes. Biochim Biophys Acta 1790: 863-868.
• Levenga J, de Vrij FM, Oostra BA, Willemsen R (2010) Potential therapeutic interventions for fragile X syn¬drome. Trends Mol Med 16: 516-527.
• Li H, Yamagata T, Mori M, Yasuhara A, Momoi MY (2005) Mutation analysis of methyl-CpG binding protein family genes in autistic patients. Brain Dev 27: 321-325.
• Lima FT, Brunoni D, Schwartzman JS, Pozzi MC, Kok F, Juliano Y, Pereira Lda V (2009) Genotype-phenotype cor¬relation in Brazillian Rett syndrome patients. Arq Neuropsiquiatr 67: 577-584.
• Lin C, Franco B, Rosner MR (2005) CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders. Hum Mol Genet 14: 3775-3786.
• Lubin FD (2012) Epileptogenesis: can the science of epige¬netics give us answers? Epilepsy Curr 12: 105-110.
• Mackay DJ, Temple IK (2010) Transient neonatal diabetes mellitus type 1. Am J Med Genet C Semin Med Genet. 154C:335-342.
• Manipalviratn S, DeCherney A, Segars J (2009) Imprinting disorders and assisted reproductive technology. Fertil Steril 91: 305-315.
• Mari F, Azimonti S, Bertani I, Bolognese F, Colombo E, Caselli R, Scala E, Longo I, Grosso S, Pescucci C, Ariani F, Hayek G, Balestri P, Bergo A, Badaracco G, Zappella M, Broccoli V, Renieri A, Kilstrup-Nielsen C, Landsberger N (2005) CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 14: 1935¬1946.
• Miremadi A, Oestergaard MZ, Pharoah PD, Caldas C (2007) Cancer genetics of epigenetic genes. Hum Mol Genet 16: R28-49.
• Mogi M, Harada M, Narabayashi H, Inagaki H, Minami M, Nagatsu T (1996) Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci Lett 211: 13-16.
• van Montfoort AP, Hanssen LL, de Sutter P, Viville S, Geraedts JP, de Boer P (2012) Assisted reproduction treatment and epigenetic inheritance. Hum Reprod Update 18: 171-197.
• Neumann LC, Markaki Y, Mladenov E, Hoffmann D, Buiting K, Horsthemke B (2012) The imprinted NPAP1/ C15orf2 gene in the Prader-Willi syndrome region encodes a nuclear pore complex associated protein. Hum Mol Genet 21: 4038-4048.
• Nimura K, Ura K, Kaneda Y (2010) Histone methyltrans- ferases: regulation of transcription and contribution to human disease. J Mol Med (Berl) 88: 1213-1220.
• Ohhata T, Wutz A (2012) Reactivation of the inactive X chromosome in development and reprogramming. Cell Mol Life Sci [Epub ahead of print].
• Oostra BA, Willemsen R (2009) FMR1: a gene with three faces. Biochim Biophys Acta 1790: 467-477.
• O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG, Carvill G, Kumar A, Lee C, Ankenman K, Munson J, Hiatt JB, Turner EH, Levy R, O'Day DR, Krumm N, Coe BP, Martin BK, Borenstein E, Nickerson DA, Mefford HC, Doherty D, Akey JM, Bernier R, Eichler EE, Shendure J (2012) Multiplex targeted sequencing identifies recurrently mutated genes in Autism spectrum disorders. Science 338: 1619-1622.
• Owen CM, Segars JH Jr (2009) Imprinting disorders and assisted reproductive technology. Semin Reprod Med 27: 417-428.
• Pereira PM, Schneider A, Pannetier S, Heron D, Hanauer A (2010) Coffin-Lowry syndrome. Eur J Hum Genet 18: 627-633.
• Pfeiffer BE, Huber KM (2009) The state of synapses in frag¬ile X syndrome. Neuroscientist. 15: 549-567.
• Plenge RM, Stevenson RA, Lubs HA, Schwartz CE, Willard HF (2002) Skewed X-chromosome inactivation is a com¬mon feature of X-linked mental retardation disorders. Am J Hum Genet 71: 168-173.
• Portela A, Esteller M (2010) Epigenetic modifications and human disease. Nat Biotechnol 28: 1057-1068.
• Psoni S, Sofocleous C, Traeger-Synodinos J, Kitsiou-Tzeli S, Kanavakis E, Fryssira-Kanioura H (2010) Phenotypic and genotypic variability in four males with MECP2 gene sequence aberrations including a novel deletion. Pediatr Res 67: 551-556.
• Qiu J, Shi G, Jia Y, Li J, Wu M, Li J, Dong S, Wong J (2010) The X-linked mental retardation gene PHF8 is a histone demethylase involved in neuronal differentiation. Cell Res 20: 908-918.
• Qureshi IA, Mehler MF (2012) Emerging roles of non-cod¬ing RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci 13: 528-541.
• Qureshi IA, Mehler MF (2010) Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiol Dis 39: 53-60.
• Ramocki MB, Tavyev YJ, Peters SU (2010) The MECP2 dupli¬cation syndrome. Am J Med Genet A 152A: 1079-1088.
• Ravn K, Roende G, Duno M, Fuglsang K, Eiklid KL, Tümer Z, Nielsen JB, Skjeldal OH (2011) Two new Rett syn¬drome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations. Orphanet J Rare Dis 6: 58.
• Razin A, Kantor B (2005) DNA methylation in epigenetic control of gene expression. Prog Mol Subcell Biol 38: 151-167.
• Rejeb I, Ben Jemaa L, Chaabouni H (2009) X linked mental retardation. Tunis Med 87: 311-318.
• Ricciardi S, Kilstrup-Nielsen C, Bienvenu T, Jacquette A, Landsberger N, Broccoli V (2009) CDKL5 influences RNA splicing activity by its association to the nuclear speckle molecular machinery. Hum Mol Genet 18: 4590¬4602.
• Riday TT, Dankoski EC, Krouse MC, Fish EW, Walsh PL, Han JE, Hodge CW, Wightman RM, Philpot BD, Malanga CJ (2012) Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome. J Clin Invest 122: 4544-4554.
• Rio M, Clech L, Amiel J, Faivre L, Lyonnet S, Le Merrer M, Odent S, Lacombe D, Edery P, Brauner R, Raoul O, Gosset P, Prieur M, Vekemans M, Munnich A, Colleaux L, Cormier-Daire V (2003) Spectrum of NSD1 mutations in Sotos and Weaver syndromes. J Med Genet 40: 436-440.
• Roche-Martinez A, Gerotina E, Armstrong-Moron J, Sans- Capdevila O, Pineda M (2011) FOXG1, a new gene responsible for the congenital form of Rett syndrome - in Spanish. Rev Neurol 52: 597-602.
• Roelfsema JH, Peters DJ (2007) Rubinstein-Taybi syn¬drome: clinical and molecular overview. Expert Rev Mol Med 9: 1-16.
• Rzońca SO, Gos M (2012) Role of FMRP protein: function and role in pathogenesis of Fragile X Syndrome (in Polish). Postępy Biologii Komórki 39: 459-476.
• Sahoo T, del Gaudio D, German JR, Shinawi M, Peters SU, Person RE, Garnica A, Cheung SW, Beaudet AL (2008) Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet 40: 719-721.
• Santos-Rebouęas CB, Fintelman-Rodrigues N, Jensen LR, Kuss AW, Ribeiro MG, Campos M Jr, Santos JM, Pimentel MM (2011) A novel nonsense mutation in KDM5C/ JARID1C gene causing intellectual disability, short stature and speech delay. Neurosci Lett 498: 67-71.
• Saul RA, Tarleton JC (2012) FMR1-related disorders. In: GeneReviews™ [Internet] (Pagon RA, Bird TD, Dolan CR, et al., Eds). University of Washington, Seattle, WA [Available at http://www.ncbi.nlm.nih.gov/books/ NBK1384/]
• Savage T, Peek J, Hofman PL, Cutfield WS (2011) Childhood outcomes of assisted reproductive technology. Hum Reprod 26: 2392-2400.
• Schwartzman JS, Bernardino A, Nishimura A, Gomes RR, Zatz M (2001) Rett syndrome in a boy with a 47,XXY karyotype confirmed by a rare mutation in the MECP2 gene. Neuropediatrics 32: 162-164.
• Shorvon SD (2011) The etiologic classification of epilepsy. Epilepsia 52: 1052-1057.
• Smith FM, Garfield AS, Ward A (2006) Regulation of growth and metabolism by imprinted genes. Cytogenet Genome Res 113: 279-291.
• Stuss DP, Boyd JD, Levin DB, Delaney KR (2012) MeCP2 mutation results in compartment-specific reductions in dendritic branching and spine density in layer 5 motor cortical neurons of YFP-H mice. PLoS One 7: e31896.
• Tan WH, Bacino CA, Skinner SA, Anselm I, Barbieri-Welge R, Bauer-Carlin A, Beaudet AL, Bichell TJ, Gentile JK, Glaze DG, Horowitz LT, Kothare SV, Lee HS, Nespeca MP, Peters SU, Sahoo T, Sarco D, Waisbren SE, Bird LM (2011) Angelman syndrome: Mutations influence features in early childhood. Am J Med Genet A 155A: 81-90.
• Temudo T, Santos M, Ramos E, Dias K, Vieira JP, Moreira A, Calado E, Carrilho I, Oliveira G, Levy A, Barbot C, Fonseca M, Cabral A, Cabral P, Monteiro J, Borges L, Gomes R, Mira G, Pereira SA, Santos M, Fernandes A, Epplen JT, Sequeiros J, Maciel P (2011) Rett syndrome with and without detected MECP2 mutations: an attempt to redefine phenotypes. Brain Dev 33: 69-76.
• Tran S, Wang L, Le J, Guan J, Wu L, Zou J, Wang Z, Wang J, Wang F, Chen X, Cai L, Lu X, Zhao H, Guo J, Bao Y, Zheng X, Zhang T (2012) Altered methylation of the DNA repair gene MGMT is associated with neural tube defects. J Mol Neurosci 47: 42-51.
• Tsurusaki Y, Okamoto N, Ohashi H, Kosho T, Imai Y, Hibi-Ko Y, Kaname T, Naritomi K, Kawame H, Wakui K, Fukushima Y, Homma T, Kato M, Hiraki Y, Yamagata T, Yano S, Mizuno S, Sakazume S, Ishii T, Nagai T, Shiina M, Ogata K, Ohta T, Niikawa N, Miyatake S, Okada I, Mizuguchi T, Doi H, Saitsu H, Miyake N, Matsumoto N (2012) Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. Nat Genet 44: 376-378.
• Urdinguio RG, Sanchez-Mut JV, Esteller M (2009) Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 8: 1056-1072.
• van Bokhoven H, Kramer JM (2010) Disruption of the epi- genetic code: an emerging mechanism in mental retarda¬tion. Neurobiol Dis 39: 3-12.
• Van der Aa N, Van den Bergh M, Ponomarenko N, Verstraete L, Ceulemans B, Storm K (2011) Analysis of FOXG1 is highly recommended in male and female patients with Rett syndrome. Mol Syndromol 1: 290-293.
• Van Esch H (2010) MECP2 duplication syndrome. In: GeneReviews™ [Internet] (Pagon RA, Bird TD, Dolan CR, et al., Eds) University of Washington, Seattle, WA [Available at: http://www.ncbi.nlm.nih.gov/books/NBK1284/]
• Van Houdt JK, Nowakowska BA, Sousa SB, van Schaik BD, Seuntjens E, Avonce N, Sifrim A, Abdul-Rahman OA, van den Boogaard MJ, Bottani A, Castori M, Cormier- Daire V, Deardorff MA, Filges I, Fryer A, Fryns JP, Gana S, Garavelli L, Gillessen-Kaesbach G, Hall BD, Horn D, Huylebroeck D, Klapecki J, Krajewska-Walasek M, Kuechler A, Lines MA, Maas S, Macdermot KD, McKee S, Magee A, de Man SA, Moreau Y, Morice-Picard F, Obersztyn E, Pilch J, Rosser E, Shannon N, Stolte- Dijkstra I, Van Dijck P, Vilain C, Vogels A, Wakeling E, Wieczorek D, Wilson L, Zuffardi O, van Kampen AH, Devriendt K, Hennekam R, Vermeesch JR (2012) Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome. Nat Genet 44: 445-449.
• Vinueza Veloz MF, Buijsen RA, Willemsen R, Cupido A, Bosman LW, Koekkoek SK, Potters JW, Oostra BA, De Zeeuw CI (2012) The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impair¬ments in Fmrl KO mice. Genes Brain Behav 11: 325¬331.
• Wang L, Wang F, Guan J, Le J, Wu L, Zou J, Zhao H, Pei L, Zheng X, Zhang T (2010) Relation between hypomethy- lation of long interspersed nucleotide elements and risk of neural tube defects. Am J Clin Nutr 91: 1359-1367.
• Weng MK, Zimmer B, Pöltl D, Broeg MP, Ivanova V, Gaspar JA, Sachinidis A, Wüllner U, Waldmann T, Leist M (2012) Extensive transcriptional regulation of chroma¬tin modifiers during human neurodevelopment. PLoS One. 7: e36708.
• Willemsen R, Levenga J, Oostra BA (2011) CGG repeat in the FMR1 gene: size matters. Clin Genet 80: 214-225.
• Williams CA, Driscoll DJ, Dagli AI (2010) Clinical and genetic aspects of Angelman syndrome. Genet Med 12: 385-395.
• Williams SR, Aldred MA, Der Kaloustian VM, Halal F, Gowans G, McLeod DR, Zondag S, Toriello HV, Magenis RE, Elsea SH (2010) Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behav¬ioral problems. Am J Hum Genet 87: 219-228.
• Yamazawa K, Ogata T, Ferguson-Smith AC (2010) Uniparental disomy and human disease: an overview. Am J Med Genet C Semin Med Genet 154C: 329-334.
• Yonath H, Marek-Yagel D, Resnik-Wolf H, Abu-Horvitz A, Baris HN, Shohat M, Frydman M, Pras E (2011) X inac- tivation testing for identifying a non-syndromic X-linked mental retardation gene. J Appl Genet 52: 437-441.
• Zhang Q, Bouma GJ, McClellan K, Tobet S (2012) Hypothalamic expression of snoRNA Snord116 is consis¬tent with a link to the hyperphagia and obesity symptoms of Prader-Willi syndrome. Int J Dev Neurosci 30: 479¬485.

Uwagi

Rekord w opracowaniu